SECOND-GENERATION ANTIPSYCHOTIC ADVERSE EFFECT MANAGEMENT

被引:0
|
作者
DelBello, Melissa P. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
关键词
D O I
10.1016/j.jaac.2023.07.312
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
37.3
引用
收藏
页码:S56 / S56
页数:1
相关论文
共 50 条
  • [21] Second-Generation Antipsychotic Agents: A Review of Safety Profiles
    Yurkov, Vladimir
    Jha, Sarita
    Collins, David M.
    Alessi-Severini, Silvia
    CURRENT PSYCHIATRY REVIEWS, 2012, 8 (01) : 49 - 68
  • [22] Monitoring of patients given second-generation antipsychotic agents
    Olson, Kari L.
    Delate, Thomas
    Duagn, Daniel J.
    PSYCHIATRIC SERVICES, 2006, 57 (07) : 1045 - 1046
  • [23] Weight gain and diabetes with "second-generation" antipsychotic drugs
    Firestone, A
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (12) : 652 - 653
  • [24] Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?
    Fang, Fang
    Wang, Zuowei
    Wu, Renrong
    Calabrese, Joseph R.
    Gao, Keming
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 407 - 418
  • [25] Reply to "Dosing equivalency of second-generation antipsychotic medications"
    Davis, JM
    Chen, N
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 502 - 503
  • [26] Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
    Kuo, Chian-Jue
    Yang, Shu-Yu
    Liao, Ya-Tang
    Chen, Wei J.
    Lee, Wen-Chung
    Shau, Wen-Yi
    Chang, Yao-Tung
    Tsai, Shang-Ying
    Chen, Chiao-Chicy
    SCHIZOPHRENIA BULLETIN, 2013, 39 (03) : 648 - 657
  • [27] PERSISTENT HYPERGLYCEMIA SECONDARY TO SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS
    Arrese, N. Soulages
    Middleman, A. B.
    Meyer, J. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 382 - 383
  • [28] Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth
    Ho, Josephine
    Panagiotopoulos, Constadina
    McCrindle, Brian
    Grisaru, Silviu
    Pringsheim, Tamara
    PAEDIATRICS & CHILD HEALTH, 2012, 17 : 5B - 11B
  • [29] Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth
    Ho, Josephine
    Panagiotopoulos, Constadina
    McCrindle, Brian
    Grisaru, Silviu
    Pringsheim, Tamara
    PAEDIATRICS & CHILD HEALTH, 2011, 16 (09) : 575 - 580
  • [30] Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
    Divac, Nevena
    Prostran, Milica
    Jakovcevski, Igor
    Cerovac, Natasa
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014